TrialEndocrine2018

Long-term safety of long-acting octreotide in patients with diabetic retinopathy: results of pooled data from 2 randomized, double-blind, placebo-controlled phase 3 studies.

Rosario Pivonello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.